Foxy-5, a WNT5A peptide mimic, reduces the metastatic capacity of invasive breast cancer via epithelial discoidin domain-containing receptor 1 (DDR1), which decreases the motility and the invasive potential of breast epithelial cells [75,76,77]. Here, DDR1 is linked to breast carcinoma.